Filing Details
- Accession Number:
- 0001396677-11-000034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-27 17:39:46
- Reporting Period:
- 2011-09-23
- Filing Date:
- 2011-09-27
- Accepted Time:
- 2011-09-27 17:39:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1050007 | Nutraceutical International Corp | NUTR | Medicinal Chemicals & Botanical Products (2833) | 870515089 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1079725 | Ii W Frank Gay | Nutracetical International Corp 1400 Kearns Blvd 2Nd Fl. Park City UT 84060 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-14 | 13,000 | $0.00 | 727,899 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2011-09-23 | 5,000 | $3.50 | 732,899 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-09-23 | 5,000 | $13.24 | 727,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-09-26 | 7,000 | $3.50 | 734,899 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-09-26 | 7,000 | $13.24 | 727,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-09-27 | 5,900 | $3.50 | 733,799 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-09-27 | 5,900 | $13.47 | 727,899 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Exercise of options expiring on December 13, 2011.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2011.
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.12 to $13.31. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The price shown in this Column 4 is a weighted average sale price. The price range for the sales is $13.15 to $13.30. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.31 to $13.60. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exhange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
